University of Alabama at Birmingham Comprehensive Care Center
Mesothelioma Treatment Section
1824 6th Avenue South
Birmingham, Alabama 35294
The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center is a Comprehensive Cancer Center designated by the National Cancer Institute (NCI).
The Cancer Center treats all types of cancers (both rare and common) including, but not limited to: breast cancer, ovarian cancer, and lung cancer.
The UAB Comprehensive Cancer Center’s history can be traced back to the early-1970s. Over the course of several decades, with the help of numerous grants, the Cancer Center was able to grow at a rapid pace and dedicate hundreds and thousands of square feet to cancer research and treatment.
The very first UAB Cancer Center grant was funded in 1972. Some $4.3 million was granted during the course of three years, and it was converted to a Cancer Center Core Support Grant in February of 1975. Through this grant, roughly 24,000 square feet of space was dedicated to genetics, virology, immunology, and NMR research. The funds, were raised by the Lurleen Wallace Courage Crusade, and combined with matching funds from the National Cancer Institute and the University Hospital.
Over the course of the next decade or so, the UAB Cancer Center was able to add another 72,000 square feet of space dedicated to Special Cancer Research, space for biohazardous research, the School of Medicine’s McCallum Basic Health Sciences Building, and laboratory research space -including a Pathogen Free Rodent facility.
Today, the UAB Comprehensive Cancer Center is funded by more than $100 million in federal and private funds, and is internationally recognized for its multidisciplinary collaborations. The Center has more than 300 faculty members including basic researchers who work in laboratories, researches with a focus on “translational” research, and other members who are “physician-scientists,” working in both patient care and laboratory settings.
The UAB Comprehensive Cancer Center is recognized as a national leader in cancer research and treatment, and it has numerous SPORE grants — “Specialized Program of Research Excellence,” and it receives thousands of donations yearly from those interested in contributing financially to cancer research and treatment. Awarded by the NCI, SPORE grants are extremely competitive, multimillion-dollar grants awarded to institutions with proven track records of interdisciplinary research. These grants are designed to “move laboratory findings quickly and safely into the clinical setting.” The UAB Comprehensive Cancer Center has a total of four SPORE grants including: breast cancer ($13 million), brain tumor ($11.8 million), ovarian cancer ($9 million), and pancreatic cancer ($4.5 million).